je.st
news
Grafix Demonstrates Superior Clinical Outcomes Compared With EpiFix In Real World' Study
2016-05-03 03:28:13| drugdiscoveryonline News Articles
Osiris Therapeutics, Inc., a leading cellular and regenerative medicine company, focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announces the results of A Retrospective, Single-Center, Non-Randomized, Cross-Sectional Comparative Effectiveness Study Evaluating Surface Area Reduction, Volume Reduction and Closure Rates in Acute and Chronic Wounds Managed with Grafix versus EpiFix
Tags: real
world
study
compared
Category:Biotechnology and Pharmaceuticals